APPLICATION
ANDA065197
TYPE
ANDA
ORIGINAL APPROVAL
2006-08-29
LATEST ACTION
2020-05-10
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
CEFOTAXIME SODIUMDiscontinued
CEFOTAXIME SODIUM EQ 2GM BASE/VIAL · INJECTABLE · INJECTION
CEFOTAXIMEDiscontinued
CEFOTAXIME SODIUM EQ 1GM BASE/VIAL · INJECTABLE · INJECTION
CEFOTAXIME SODIUMDiscontinued
CEFOTAXIME SODIUM EQ 500MG BASE/VIAL · INJECTABLE · INJECTION
Approval history
2020-05-10Labeling · Supplement 3 · standardAP
2008-06-20Labeling · Supplement 2AP
2006-08-29OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.